ArticleInfection and drug resistance2020
Development and Validation of a Model for Predicting the Risk of Death in Patients with
Article in Infection and drug resistance, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Risk factors and predictive model for nosocomial infections by extensively drug-resistantFrontiers in cellular and infection microbiology · 2024Article
- Nomogram for predicting 90-day mortality in patients withThe Journal of international medical research · 2023Article
- Establishment and Validation of Models for the Risk of Multi-Drug Resistant Bacteria Infection and Prognosis in Elderly Patients with Pulmonary Infection: A Multicenter Retrospective Study.Infection and drug resistance · 2023Article
- Establishment and Validation of a Risk Prediction Model for Mortality in Patients withInfection and drug resistance · 2023Article
- Treatment, Clinical Outcomes, and Predictors of Mortality among a National Cohort of Admitted Patients withAntimicrobial agents and chemotherapy · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to develop and validate a personalized prediction model of death risk in patients with PATIENTS AND
methodsThe development group is comprised of 350 patients with
resultsThe infectious source, carbapenem-resistant
conclusionThe proposed model helped predict the risk of death from
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.